249 related articles for article (PubMed ID: 38609037)
21. The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver disease.
Van Eyck A; Kwanten WJ; Peleman C; Makhout S; Van Laere S; Van De Maele K; Van Hoorenbeeck K; De Man J; De Winter BY; Francque S; Verhulst SL
Int J Obes (Lond); 2024 Apr; 48(4):512-522. PubMed ID: 38142264
[TBL] [Abstract][Full Text] [Related]
22. Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.
Zhang F; Lo EKK; Chen J; Wang K; Felicianna ; Ismaiah MJ; Leung HKM; Zhao D; Lee JC; El-Nezami H
J Agric Food Chem; 2024 Apr; 72(15):8536-8549. PubMed ID: 38575146
[TBL] [Abstract][Full Text] [Related]
23. The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies.
Salvoza N; Giraudi P; Gazzin S; Bonazza D; Palmisano S; de Manzini N; Zanconati F; Raseni A; Sirianni F; Tiribelli C; Rosso N
J Transl Med; 2023 Dec; 21(1):906. PubMed ID: 38082368
[TBL] [Abstract][Full Text] [Related]
24. Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Liu H; Yerevanian A; Westerhoff M; Hastings MH; Guerra JRB; Zhao M; Svensson KJ; Cai B; Soukas AA; Rosenzweig A
Diabetes; 2024 Feb; 73(2):260-279. PubMed ID: 37934943
[TBL] [Abstract][Full Text] [Related]
25. ANGPTL2 knockdown induces autophagy to relieve alveolar macrophage pyroptosis by reducing LILRB2-mediated inhibition of TREM2.
Yang F; Chen M; Liu Y; Hu Y; Chen Y; Yu Y; Deng L
J Cell Mol Med; 2024 May; 28(10):e18280. PubMed ID: 38758159
[TBL] [Abstract][Full Text] [Related]
26. Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.
Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Casalino A; Bocca C; Novo E; Protopapa F; Ramavath NN; Provera A; Gambella A; Bugianesi E; Tacke F; Albano E; Parola M
Front Immunol; 2024; 15():1342404. PubMed ID: 38469298
[TBL] [Abstract][Full Text] [Related]
27. Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periosti.
Xie W; Gan J; Zhou X; Tian H; Pan X; Liu W; Li X; Du J; Xu A; Zheng M; Wu F; Li Y; Lin Z
Cell Metab; 2024 Jun; 36(6):1269-1286.e9. PubMed ID: 38838640
[TBL] [Abstract][Full Text] [Related]
28. Triggering receptor expressed on myeloid Cells-2 (TREM2) inhibits steroidogenesis in adrenocortical cell by macrophage-derived exosomes in lipopolysaccharide-induced septic shock.
Ye H; Zhai Q; Fang P; Yang S; Sun Y; Wu S; Huang R; Chen Q; Fang X
Mol Cell Endocrinol; 2021 Apr; 525():111178. PubMed ID: 33556472
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction-associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease.
Swan J; Szabó Z; Peters J; Kummu O; Kemppi A; Rahtu-Korpela L; Konzack A; Hakkola J; Pasternack A; Ritvos O; Kerkelä R; Magga J
Biomed Pharmacother; 2024 Jun; 175():116683. PubMed ID: 38705130
[TBL] [Abstract][Full Text] [Related]
30. Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis.
Endo-Umeda K; Kim E; Thomas DG; Liu W; Dou H; Yalcinkaya M; Abramowicz S; Xiao T; Antonson P; Gustafsson JÅ; Makishima M; Reilly MP; Wang N; Tall AR
Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):719-731. PubMed ID: 35477277
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles and Their Correlation with Inflammatory Factors in an Experimental Model of Steatotic Liver Disease Associated with Metabolic Dysfunction.
Keingeski MB; Longo L; Brum da Silva Nunes V; Figueiró F; Dallemole DR; Pohlmann AR; Vier Schmitz TM; da Costa Lopez PL; Álvares-da-Silva MR; Uribe-Cruz C
Metab Syndr Relat Disord; 2024 Jun; 22(5):394-401. PubMed ID: 38498801
[No Abstract] [Full Text] [Related]
32. DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response.
Zhong L; Chen XF; Zhang ZL; Wang Z; Shi XZ; Xu K; Zhang YW; Xu H; Bu G
J Biol Chem; 2015 Jun; 290(25):15866-15877. PubMed ID: 25957402
[TBL] [Abstract][Full Text] [Related]
33. Function of TREM1 and TREM2 in Liver-Related Diseases.
Sun H; Feng J; Tang L
Cells; 2020 Dec; 9(12):. PubMed ID: 33297569
[TBL] [Abstract][Full Text] [Related]
34. The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis.
Burmeister Y; Weyer K; Dörre A; Seilheimer B
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137437
[TBL] [Abstract][Full Text] [Related]
35. TREM2 regulates obesity-induced insulin resistance via adipose tissue remodeling in mice of high-fat feeding.
Liu C; Li P; Li H; Wang S; Ding L; Wang H; Ye H; Jin Y; Hou J; Fang X; Shu Q
J Transl Med; 2019 Sep; 17(1):300. PubMed ID: 31477129
[TBL] [Abstract][Full Text] [Related]
36. Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH.
Zhang D; Zhao Y; Zhang G; Lank D; Cooke S; Wang S; Nuotio-Antar A; Tong X; Yin L
Mol Metab; 2024 Jul; 85():101957. PubMed ID: 38740087
[TBL] [Abstract][Full Text] [Related]
37. Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.
Kjærgaard K; Daugaard Mikkelsen AC; Landau AM; Eriksen PL; Hamilton-Dutoit S; Magnusson NE; Thomsen MB; Chen F; Vilstrup H; Mookerjee RP; Bay-Richter C; Thomsen KL
JHEP Rep; 2024 Mar; 6(3):100992. PubMed ID: 38415019
[TBL] [Abstract][Full Text] [Related]
38. Geniposide Enhances Macrophage Autophagy through Downregulation of TREM2 in Atherosclerosis.
Xu YL; Liu XY; Cheng SB; He PK; Hong MK; Chen YY; Zhou FH; Jia YH
Am J Chin Med; 2020; 48(8):1821-1840. PubMed ID: 33308094
[TBL] [Abstract][Full Text] [Related]
39. Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8
Zheng C; Wang L; Zou T; Lian S; Luo J; Lu Y; Hao H; Xu Y; Xiang Y; Zhang X; Xu G; Zou X; Jiang R
J Hepatol; 2024 May; 80(5):764-777. PubMed ID: 38181823
[TBL] [Abstract][Full Text] [Related]
40. The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα.
Clavreul L; Bernard L; Cotte AK; Hennuyer N; Bourouh C; Devos C; Helleboid A; Haas JT; Verrijken A; Gheeraert C; Derudas B; Guille L; Chevalier J; Eeckhoute J; Vallez E; Dorchies E; Van Gaal L; Lassailly G; Francque S; Staels B; Paumelle R
Metabolism; 2024 Feb; 151():155720. PubMed ID: 37926201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
